Title:
新規オキサジアジノン誘導体およびそれらの使用
Document Type and Number:
Japanese Patent JP2008515827
Kind Code:
A
Abstract:
The invention relates to novel 1,3,4-oxadiazine-5-on derivatives of general formula (I), methods for the production thereof, the use thereof for treating and/or preventing diseases, and the use thereof for producing medicaments used for the treatment and/or prevention of diseases, preferably cardiovascular diseases, especially dyslipidemia and arteriosclerosis.
Inventors:
Erke Ditrich-Wengenroth
Lars Belfucker
Axel Kletschmer
Claudia Hirth-Dietrich
Peter Ellinghouse
Martin Rabe
Hilmar Bischoff
Christian Pilger
Ulrich Rosentrator
Stephan Bartel
Clemens Rustig
Armin Cologne
Dieter Lang
Lars Belfucker
Axel Kletschmer
Claudia Hirth-Dietrich
Peter Ellinghouse
Martin Rabe
Hilmar Bischoff
Christian Pilger
Ulrich Rosentrator
Stephan Bartel
Clemens Rustig
Armin Cologne
Dieter Lang
Application Number:
JP2007535055A
Publication Date:
May 15, 2008
Filing Date:
September 27, 2005
Export Citation:
Assignee:
Bayer HealthCare AG
International Classes:
C07D273/04; A61K31/5395; A61P3/06; A61P9/10; C07D413/12
Attorney, Agent or Firm:
Mitsuo Tanaka
Takuji Yamada
Mitsutaka Iwasaki
Aoyama Aoi
Yasuo Shibata
Takuji Yamada
Mitsutaka Iwasaki
Aoyama Aoi
Yasuo Shibata